Mount Sinai Is Among First to Use Blood Tests as Early Detection Tool for Alzheimer’s Disease and Related Dementias in Patients
The Mount Sinai Health System is among the first in the world to deploy blood-based biomarkers and confirmatory tests for Alzheimer’s disease and related dementias to patients across primary and specialty care settings.